Basal Cell Carcinoma Treatment Market Trends, Growth & Forecast | 2022-27
Market Overview:
During the forecast period, the basal cell carcinoma treatment market is expected to grow at a CAGR of 9.3%. The increasing prevalence of skin malignancies, rise in various environmental factors, which leads to more UV exposure, and increasing geriatric population who are more susceptible to skin diseases are the major factors driving market growth.
According to the Skin Cancer Foundation, exposure to ultraviolet radiation causes approximately 90% of nonmelanoma skin cancers, and basal cell carcinoma is the most common type of skin cancer. Every year, an estimated 4.3 million cases of BCC are diagnosed in the United States. However, high susceptibility of basal cell carcinoma to remain under-diagnosed and the high cost of the treatment are the constraints to the growth of the market
Scope of the Report:
Basal cell carcinoma, according to the scope of the report, is a type of skin cancer that begins in the basal cells, which produce new cells when the old ones die. The Basal Cell Carcinoma Treatment market is divided into three components: Treatment Type, End-user, and Geography.
Comments
Post a Comment